News

By Deena Beasley (Reuters) -Gilead Sciences' Trodelvy in combination with Merck's blockbuster immunotherapy Keytruda lowered ...
The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...
The new treatment will deliver chemotherapy directly to cancer cells. Read more at straitstimes.com. Read more at ...
Often, when young women approach their care teams with concerns about breast cancer, they're brushed aside. It’s our ...
A new pre-surgery treatment strategy for inherited breast cancer has achieved an astonishing 100% survival rate, thanks to a ...
Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...
While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...
HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 ...
The RHOA personality was diagnosed with stage 1 invasive ductal carcinoma in November 2024. She recently reflected on the ...